Beryl Capital Management LLC 13D and 13G filings for Checkpoint Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 12:34 pm Sale | 2025-06-30 | 13G | Checkpoint Therapeutics, Inc. CKPT | Beryl Capital Management LLC | 0 0.000% | -6,074,216 (Position Closed) | Filing |
| 2025-03-17 5:04 pm Purchase | 2025-03-10 | 13G | Checkpoint Therapeutics, Inc. CKPT | Beryl Capital Management LLC | 6,074,216 9.900% | 6,074,216 (New Position) | Filing |